Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy

Yanqing Li

Status

Unknown

Conditions

Health Policy

Cancer of Esophagus

Capsule Endoscopy

Cancer of Stomach

Treatments

Other: Medical Consortium

Study type

Interventional

Funder types

Other

Identifiers

NCT04032353

2019SDU-QILU-150

Details and patient eligibility

About

The aim of our study was to demonstrate the efficacy and feasibility of the medical consortium for screening upper gastrointestinal cancers with magnetically controlled capsule gastroscopy.

Full description

In this study, the investigators designed a propective cohort study to evaluate the the efficacy and feasibility of medical consortium for screening upper gastrointestinal cancers (MCSC) with magnetically controlled capsule gastroscopy (MCCG).

Enrollment

10,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

asymptomatic subjects undergong magnetically controlled capsule gastroscopy for health checkup in medical consotium;
subjects able to give informed consent

Exclusion criteria

suspected or known intestinal stenosis, obstruction, or fistula;
inoperability of refusal to accept any abdominal surgery;
dysphagia or gastric paralysis;
previous history of gastrointestinal disease;
with pacemaker, implanted-cardiac defibrillator or other implanted electromedical devices;
need for standard magnetic resonance imaging examination within seven days after swallowing the MCCG, unless the capsule is confirmed to have been excreted;
other factors that are not suitable for inclusion evaluated by medical stuff